A common assumption is that PCOS ends at menopause — the cycles stop, so the condition stops. Some of it does ease. The metabolic and cardiovascular parts do not, and they matter more after menopause rather than less. Here is what actually happens, and what to keep an eye on.

Where we stand: Menova is an independent publication. We sell no hormones and no supplements, we are not your doctor, and this is general education, not a diagnosis.

What tends to improve

Cycles become more regular as you approach menopause. This surprises people. Women with PCOS often have longer cycles for decades, and as the ovarian reserve declines those cycles typically shorten toward a normal length in the years before menopause — so a woman with PCOS may find her cycles regularise in her forties, then stop.

Some androgen-related features ease, since androgen levels tend to decline with age. Acne and unwanted hair growth may become less prominent, though usually not absent.

Fertility concerns end, which for some women is a relief and for others a loss worth acknowledging.

The timing question

Research suggests women with PCOS may reach menopause somewhat later on average than women without it — a difference of a couple of years is commonly cited, attributed to a larger ovarian follicle pool.

Two practical implications: a longer reproductive window means contraception matters for longer if you do not want pregnancy — see which contraception in perimenopause — and it means the metabolic issues below have more years to run before menopause even arrives.

What does not improve — and this is the part that matters

Insulin resistance persists. PCOS is associated with insulin resistance independent of weight, and menopause worsens insulin sensitivity in everyone. Those two stack rather than cancel. See insulin resistance in menopause.

Cardiometabolic risk continues, and may become more prominent. Women with PCOS carry higher rates of type 2 diabetes, unfavourable cholesterol patterns, high blood pressure, and metabolic syndrome. Cardiovascular risk also rises for all women after menopause. This is the combination worth acting on rather than assuming resolves.

Body composition changes compound. PCOS is associated with central fat distribution, and menopause shifts fat toward the abdomen independently; see menopause belly fat.

Sleep apnea risk is elevated in PCOS, and rises again after menopause. It is under-diagnosed in women, causes fatigue and fog that get attributed to hormones, and is treatable — see sleep apnea after menopause.

The screening that should not lapse

If you have PCOS, this is the decade to be deliberate rather than assume the condition is behind you:

  • HbA1c, periodically — diabetes screening matters more here than for the general population
  • Blood pressure
  • Lipid panel
  • Waist measurement, which tracks visceral fat better than weight
  • Sleep apnea assessment if you snore, wake unrefreshed, or have witnessed pauses

And one specific to PCOS: endometrial health. Years of infrequent ovulation mean the uterine lining has had prolonged estrogen exposure without regular progesterone, which is associated with a higher risk of endometrial hyperplasia and endometrial cancer. That makes any abnormal bleeding — and any bleeding after twelve months without periods — something to have assessed promptly rather than watched. See irregular periods in perimenopause and health screening in your 50s.

Can I take HRT with PCOS?

PCOS is not a contraindication, and the same considerations apply as for anyone else. Points worth raising:

  • If you have a uterus you need adequate progestogen, and given the endometrial history above that component is not somewhere to cut corners — see progesterone in menopause. A hormonal IUD is one route that delivers progestogen directly to the lining and reduces bleeding
  • Cardiometabolic risk shapes the route. Transdermal estrogen avoids first-pass liver metabolism and has not been shown to carry the clot risk associated with oral — relevant when metabolic risk is already elevated; see HRT and blood clot risk
  • Hormone therapy is not a PCOS treatment. It treats menopausal symptoms; the metabolic management continues separately

See is HRT safe for the wider picture.

What about metformin and the other PCOS treatments?

Whether to continue depends on why you were taking it. If metformin was prescribed for insulin resistance or glucose control, that reason does not end at menopause — and it may become more relevant. If it was for cycle regulation or fertility, the rationale changes.

That is a conversation rather than an assumption, and it is worth having explicitly rather than letting a prescription drift. Note also that long-term metformin lowers vitamin B12, which is worth testing given how easily B12 deficiency is mistaken for menopausal fatigue; see medications that mimic menopause.

Symptoms that get attributed to the wrong thing

With two conditions in play, each tends to get blamed for the other:

  • Fatigue → could be PCOS-related metabolic issues, menopause, sleep apnea, iron deficiency, or thyroid; see when menopause might not be the answer
  • Hair changes → PCOS-related androgen effects and menopausal hair thinning both cause scalp thinning, and both cause facial hair. Rapid onset of coarse facial hair is different and warrants assessment; see hair changes in menopause
  • Mood → both conditions are associated with higher rates of anxiety and depression, and both deserve treatment in their own right; see mood and anxiety in menopause
  • Weight → the interventions are the same either way, and they are not restriction; see midlife weight and energy

What actually helps, for both at once

Usefully, the interventions overlap almost completely:

  • Resistance training twice a week, which improves insulin sensitivity directly and protects the muscle that disposes of glucose — see starting from zero if you have not trained before
  • Protein and fibre at every meal, which flatten glucose curves; see eating for menopause
  • Walking after meals
  • Sleep, which affects insulin sensitivity measurably
  • Reducing alcohol; see alcohol in midlife

What to say

"I have PCOS and I'm going through menopause. I know the cycle side resolves, but I understand the metabolic risk doesn't. Could we check HbA1c, lipids and blood pressure, and review whether I still need metformin? And given my history of irregular cycles, what should I do about any abnormal bleeding?"

That covers the three things that actually matter here. The free printable visit prep sheet has space for the test requests and your history, and the free 2-minute self-check organizes the menopausal side — no account, not a diagnosis, and your answers never leave your device.

This article is general education, not medical advice or a diagnosis. PCOS management requires a licensed clinician. Any bleeding after twelve months without periods, or abnormal bleeding at any time, should be assessed promptly.

Sources: ACOG — PCOS, NICHD — PCOS, International Evidence-Based Guideline for PCOS, and The Menopause Society.